US Drug Testing Inc Q3 shr loss increases . Period ended December 31 1996 1995 Shr loss $ 0 . 14 loss $ 0 . 10 Net loss 721 loss 503 Sales 000 000 Avg shrs 5 , 222 5 , 222 9 MONTHS Shr loss $ 0 . 35 loss $ 0 . 23 Net loss 1 , 832 loss 1 , 194 Sales 1 , 804 1 , 445 Avg shrs 5 , 222 5 , 222 ( All data above 000s except per share numbers ) ( ( - - New York newsdesk 212 - 859 - 1610 ) ) 
